4.7 Article

Panitumumab-DOTA-111In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner-Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial

Pierre Loap et al.

Summary: Preclinical studies have shown that TNBC cell lines are more sensitive to PARP inhibitors, leading to the development of new therapeutic approaches. The RADIOPARP phase 1 trial aimed to evaluate the toxicity and maximum tolerated dose of olaparib in combination with radiation therapy for TNBC patients. The trial showed that olaparib at a dose of 200 mg twice a day was well tolerated without dose-limiting toxicities.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Chemistry, Medicinal

Auger electrons for cancer therapy - a review

Anthony Ku et al.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)

Article Multidisciplinary Sciences

Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin

Elli Narvi et al.

SCIENTIFIC REPORTS (2018)

Article Veterinary Sciences

A less invasive method for orthotopic injection of breast cancer cells into the mouse mammary gland

Luz E. Tavera-Mendoza et al.

LABORATORY ANIMALS (2017)

Article Medicine, General & Internal

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Mark Robson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

N. Masuda et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Oncology

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy

Berengere Piron et al.

NUCLEAR MEDICINE AND BIOLOGY (2014)

Article Oncology

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

Eun Yoon Cho et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)

Article Medicine, Research & Experimental

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Brian D. Lehmann et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis

Lore Santoro et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Oncology

Triple-negative breast cancer: Clinical features and patterns of recurrence

Rebecca Dent et al.

CLINICAL CANCER RESEARCH (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Induction of apoptosis in human tumor cells after exposure to Auger electrons:: comparison with γ-ray exposure

Tetsuro Urashima et al.

NUCLEAR MEDICINE AND BIOLOGY (2006)

Review Cell Biology

EGF-ERBB signalling: towards the systems level

Ami Citri et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

Review Pharmacology & Pharmacy

Elimination mechanisms of therapeutic monoclonal antibodies

MA Tabrizi et al.

DRUG DISCOVERY TODAY (2006)